Juvederm Volift Retouch with Lido (2x0,55ml)

Volift Retouch acts as a stable filling implant that binds to water within the dermis to provide mechanical correction. Unlike superficial skin boosters, it provides the structural cohesivity needed to fill deeper furrows while remaining flexible enough for dynamic facial zones like the lips.

This treatment is strictly contraindicated. There is no clinical safety data regarding Vycross-based HA injectables during pregnancy. We adhere to the highest safety standards and defer treatment until after childbirth.

The formulation contains 17.5 mg/ml of cross-linked Hyaluronic Acid of non-animal origin and 0.3% Lidocaine hydrochloride for procedural comfort.

The dosage is highly individualized, specifically designed for small-scale corrections. The 0.55 ml syringe allows for precise application without the waste of a full 1 ml syringe. Practitioners often use this version two weeks after an initial treatment with Juvederm Voluma or Volift to finalize facial contours.

Expect minor localized swelling, redness, and potential purple bruising. Due to Vycross technology, inflammatory responses are typically minimal. To ensure a quick recovery, follow our expert aftercare guide. Any persistent blanching requires immediate evaluation per our safety protocol.

Patients are advised to avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can exacerbate post-filler swelling and increase the risk of bruising at the refinement sites.

Injection is not recommended for nursing mothers. It is advised to wait until the breastfeeding period has completely concluded to avoid any potential systemic risks during elective aesthetic treatments.